Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 50, Issue 6, Pages 2244-2247Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00381-05
Keywords
-
Categories
Ask authors/readers for more resources
We assessed infections caused by extended-spectrum-beta-lactamase-producing Escherichia coli or Klebsiella spp. treated with piperacillin-tazobactam to determine if the susceptibility breakpoint predicts outcome. Treatment was successful in 10 of 11 nonurinary infections from susceptible strains and in 2 of 6 infections with MICs of > 16/4 mu g/ml. All six urinary infections responded to treatment regardless of susceptibility.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available